NCT02182544

WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis

Phase III Double-blind Comparative Study of WAL801CL Dry Syrup in Paediatric Perennial Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 151 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

Study to investigate the efficacy of WAL801CL Dry Syrup in comparison with ketotifen fumarate on pediatric perennial allergic rhinitis and to evaluate the safety of WAL801CL Dry Syrup compared to ketotifen fumarate and to confirm the appropriateness of dosage of WAL801 Dry Syrup.

Conditions

• Rhinitis, Allergic, Perennial

Interventions

Type	Name	Description
DRUG	WAL801CL dry syrup
DRUG	Ketotifen fumarate dry syrup
DRUG	Ketotifen fumarate dry syrup placebo
DRUG	WAL 801 CL dry syrup placebo

Timeline

• Start date: 2001-06-01
• Primary completion: 2001-12-01
• First posted: 2014-07-08
• Last updated: 2014-07-14